A Two-period, Randomised, Open-label, Crossover, Pharmacokinetic Study to Assess the Bioequivalence and Adhesion of Buprenorphine Transdermal System Second Generation Patch Compared With First Generation Patch, in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 17 Feb 2016
Price : $35 *
At a glance
- Drugs Buprenorphine (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Mundipharma Research
- 08 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Sep 2015 Planned End Date changed from 1 Jun 2015 to 1 Oct 2015 as per ClinicalTrials.gov record.
- 15 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.